Source-grounded facts extracted from NATIONAL HEALTH INVESTORS INC's SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
NATIONAL HEALTH INVESTORS INC shareholders approved Ratification of Independent Registered Public Accounting Firm at the 2026-05-27 meeting.
“Proposal 3 – Ratification of Independent Registered Public Accounting Firm The selection of BDO USA, P.C. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 was ratified, and the voting results were as follows: Votes For Votes Against Abstentions 41,389,140 954,425 43,388”
NATIONAL HEALTH INVESTORS INC shareholders approved Non-Binding, Advisory Vote on Executive Compensation at the 2026-05-27 meeting.
“Proposal 2 – Non-Binding, Advisory Vote on Executive Compensation The compensation paid to the Company’s named executive officers was approved, on a non-binding, advisory basis, and the voting results were as follows: Votes For Votes Against Abstentions Broker Non-Votes 30,921,601 1,349,874 1,525,825 8,589,653”
NATIONAL HEALTH INVESTORS INC shareholders approved Election of Directors at the 2026-05-27 meeting.
“Proposal 1 – Election of Directors The nominees named below were elected to serve as members of the Board of Directors of the Company until the 2027 Annual Meeting of Stockholders and until their respective successors are elected and qualified or until their earlier death, resignation or removal, and the voting results were as follows: Nominee Votes For Votes Against Abstentions Broker Non-Votes Robert W. Chapin, Jr. 31,755,734 845,203 1,196,363 8,589,653 Tracy M.J. Colden 31,321,632 988,107 1,487,561 8,589,653 Lilly H. Donohue 32,065,111 125,949 1,606,240 8,589,653 James R. Jobe 31,143,695 1,457,966 1,195,639 8,589,653 Robert A. McCabe, Jr. 30,859,078 1,740,528 1,197,694 8,589,653 D. Eric Mendelsohn 31,833,814 497,876 1,465,610 8,589,653 Candice W. Todd 31,732,706 418,367 1,646,227 8,589,653”
NATIONAL HEALTH INVESTORS INC updated its 2026 full year guidance (lowered).
“NHI is updating its 2026 full year guidance range as follows: • NAREIT FFO per diluted share from a range of $4.94 - $4.99 to a range of $4.74 - $4.79; • Normalized FFO per diluted share from a range of $4.94 - $4.99 to a range of $4.74 - $4.79; and • Normalized FAD from a range of $248.9 million - $251.4 million to a range of $240.6 million - $243.7 million.”
NATIONAL HEALTH INVESTORS INC reported the quarter ended March 31, 2026 results: EPS $0.82 per diluted share.
“Net income attributable to common stockholders per diluted share for the quarter ended March 31, 2026 increased by 10.8% to $0.82 per share compared to $0.74 per share for the same period in the prior year.”
NATIONAL HEALTH INVESTORS INC entered into Purchase and Sale Agreement with NHC/OP, L.P. and its affiliates (the Purchaser Parties) valued at $560 million (effective 2026-04-21).
“On April 21, 2026 (the “Effective Date”), National Health Investors, Inc. on behalf of itself and its affiliates identified in the Agreement (collectively, the “Company”) entered into a Purchase and Sale Agreement (the “Agreement”) with NHC/OP, L.P., a Delaware limited partnership (the “Purchaser”) and a wholly-owned subsidiary of National HealthCare Corporation (“NHC”), on behalf of itself and its affiliates identified in the Agreement, each of which is a wholly-owned subsidiary of NHC (collectively, together with the Purchaser, the “Purchaser Parties”) to sell to the Purchaser Parties the land, facilities, and improvements, including 32 skilled nursing facilities and three independent living facilities (collectively, the “Property,” and with respect to the 35 facilities, the “Facilities”), currently leased by the Purchaser Parties, as tenants, from the Company, as landlord, under a Master Agreement to Lease dated October 17, 1991, as amended, and those single Facility leases executed”
NATIONAL HEALTH INVESTORS INC incurred senior notes of $350,000,000 with Regions Bank at 5.350% maturing February 1, 2033.
“On September 26, 2025, National Health Investors, Inc. (the “Company”) completed an underwritten public offering of $350,000,000 aggregate principal amount of its 5.350% Senior Notes due 2033 (the “Notes”),”
Robert W. Chapin, Jr. was appointed as Director at NATIONAL HEALTH INVESTORS INC.
“On March 27, 2025, National Health Investors, Inc. (the “Company” or “NHI”) announced that, upon the recommendation of its Nominating and Corporate Governance Committee, it has increased the size of the Board to eight members and has appointed Robert W. Chapin, Jr. to fill the newly created seat on the Board, effective immediately.”
Robert T. Webb resigned as Director at NATIONAL HEALTH INVESTORS INC.
“On February 7, 2025, Robert T. Webb notified National Health Investors, Inc. (the “Company”) of his decision to resign from his position as a member of the Board of Directors (the “Board”) effective immediately.”
Candice Todd was appointed as Member of the Special Committee related to the National HealthCare Corporation potential lease at NATIONAL HEALTH INVESTORS INC.
“Appointed Ms. Todd as a member of the Special Committee related to the National HealthCare Corporation potential lease.”
Candice Todd was appointed as Member of the Nominating and Corporate Governance Committee at NATIONAL HEALTH INVESTORS INC.
“Appointed Ms. Todd as a member of the Nominating and Corporate Governance Committee;”
Candice Todd was appointed as Chairperson of the Audit Committee at NATIONAL HEALTH INVESTORS INC.
“Appointed Ms. Todd as Chairperson of the Audit Committee;”
Candice W. Todd was appointed as Director at NATIONAL HEALTH INVESTORS INC.
“on December 2, 2024, the Company announced that upon the recommendation of its Nominating and Corporate Governance Committee, it has appointed Candice W. Todd to fill the soon to be vacant seat on the Board, effective January 1, 2025.”
W. Andrew Adams retired as Director at NATIONAL HEALTH INVESTORS INC.
“on November 5, 2024 the Company announced the retirement of Mr. W. Andrew Adams from the Board effective December 31, 2024.”
W. Andrew Adams retired as Chairperson and Member of the Board of Directors at NATIONAL HEALTH INVESTORS INC.
“W. Andrew Adams notified National Health Investors, Inc. (the “Company”) of his decision to retire from his position as Chairperson and a member of the Board of Directors (the “Board”) effective December 31, 2024.”
NATIONAL HEALTH INVESTORS INC reported three months ended March 31, 2024 results: EPS $0.71. Guidance raised.
“Net income attributable to common stockholders per diluted common share for the three months ended March 31, 2024 was $0.71 compared to $0.79 during the same period in the prior year.”
NATIONAL HEALTH INVESTORS INC reported the three and twelve months ended December 31, 2023 results: net income Net income attributable to common stockholders per diluted common share for the three months ended December 31, 2023 was, EPS Net income attributable to common stockholders per diluted common share for the three months ended December 31, 2023 was. Guidance initiated.
“NHI Announces Fourth Quarter 2023 Results MURFREESBORO, Tenn. – (February 20, 2024) National Health Investors, Inc. (NYSE:NHI) announced today its results for the three and twelve months ended December 31, 2023.”
NATIONAL HEALTH INVESTORS INC reported the three and nine months ended September 30, 2023 results: net income Net income attributable to common stockholders per diluted common share for the three months ended September 30, 2023 wa, EPS $0.68. Guidance lowered.
“NHI Announces Third Quarter 2023 Results MURFREESBORO, Tenn. – (November 7, 2023) National Health Investors, Inc. (NYSE:NHI) announced today its results for the three and nine months ended September 30, 2023.”
NATIONAL HEALTH INVESTORS INC reported 2023 results: EPS Normalized FFO per share to $4.31 - $4.35 from $4.37 - $4.42. Guidance lowered.
“NHI is revising its 2023 annual guidance range for Normalized FFO per share to $4.31 - $4.35 from $4.37 - $4.42 and is revising Normalized FAD to a range of $185.0 million - $186.8 million from $186.3 million - $188.9 million.”
NATIONAL HEALTH INVESTORS INC reported three and six months ended June 30, 2023 results: EPS Net income attributable to common stockholders per diluted common share for the three months ended June 30, 2023 was $0.. Guidance reaffirmed.
“NHI Announces Second Quarter 2023 Results MURFREESBORO, Tenn. – (August 8, 2023) National Health Investors, Inc. (NYSE:NHI) announced today its results for the three and six months ended June 30, 2023.”
NATIONAL HEALTH INVESTORS INC incurred term loan of $200.0 million with Wells Fargo Bank, National Association, as administrative agent at Term SOFR (plus a credit spread adjustment) plus a margin ranging from 0.75% to maturing June 16, 2025.
“On June 16, 2023 (the “ Effective Date ”), National Health Investors, Inc. (the “ Company ”) entered into a Term Loan Agreement (the “ Loan Agreement ”) with Wells Fargo Bank, National Association, as administrative agent (the “ Agent ”), and the financial institutions party thereto as lenders and agents, which provides for aggregate revolving loan commitments of $200.0 million (the “ Term Loan ”), which amount was fully advanced on the Effective Date.”
NATIONAL HEALTH INVESTORS INC reported for the three months ended March 31, 2023 results: EPS $0.79 per diluted common share. Guidance raised.
“Net income attributable to common stockholders per diluted common share for the three months ended March 31, 2023 was $0.79 compared to $0.18 during the same period in the prior year.”
NATIONAL HEALTH INVESTORS INC shareholders approved Ratification of BDO USA, LLP as independent registered public accounting firm at the 2023-05-05 meeting.
“The selection of BDO USA, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 was ratified, and the voting results were as follows: Votes For Votes Against Abstentions 35,828,506 230,812 55,337”
NATIONAL HEALTH INVESTORS INC shareholders approved Advisory frequency vote on executive compensation at the 2023-05-05 meeting.
“A one year frequency of the advisory vote on the compensation of executive officers was approved by the shareholders, with the following results: One Year Two Years Three Years Abstentions 27,068,457 1,252,507 1,627,053 878,547”
NATIONAL HEALTH INVESTORS INC shareholders approved Advisory vote on executive compensation at the 2023-05-05 meeting.
“The compensation paid to NHI’s named executive officers was approved with the following voting results: Votes For Votes Against Abstentions Broker Non-Votes 27,386,823 2,520,446 919,295 5,288,091”
NATIONAL HEALTH INVESTORS INC shareholders approved Approval of Amended and Restated 2019 Stock Incentive Plan at the 2023-05-05 meeting.
“The Amended and Restated 2019 Stock Incentive Plan was approved with the following voting results: Votes For Votes Against Abstentions Broker Non-Votes 21,807,045 8,131,693 887,826 5,288,091”
NATIONAL HEALTH INVESTORS INC shareholders approved Election of directors at the 2023-05-05 meeting.
“The nominees named below were elected to serve as members of the Board of Directors of the Company for a three-year term until the 2026 annual meeting of stockholders and until their successors are duly elected and qualified, and the voting results were as follows: Nominee Votes For Votes Against Abstentions Broker Non-Votes W. Andrew Adams 27,496,470 2,484,778 845,316 5,288,091 Tracy M.J. Colden 29,674,515 300,585 851,464 5,288,091 Robert A. McCabe, Jr. 24,197,664 5,781,746 847,154 5,288,091”
NATIONAL HEALTH INVESTORS INC reported financial results for the three months and year ended December 31, 2022.
“On February 21, 2023, National Health Investors, Inc. issued a press release announcing its earnings for the quarter ended December 31, 2022.”
NATIONAL HEALTH INVESTORS INC reported nine months ended September 30, 2022 results: EPS $1.43.
“Net income attributable to common stockholders per diluted common share for the nine months ended September 30, 2022 was $1.43”
NATIONAL HEALTH INVESTORS INC reported three months ended September 30, 2022 results: EPS $0.78.
“Net income attributable to common stockholders per diluted common share for the three months ended September 30, 2022 was $0.78”
Tracy M.J. Colden was appointed as Director at NATIONAL HEALTH INVESTORS INC.
“appointed Tracy M.J. Colden to fill the newly created directorship, effective June 1, 2022.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.